Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
highly purified staphylococcal bacteriophage preparation
- Development stage
- Unknown
- Lead developer
- George Eliava Institute of Bacteriophage, Microbiology and Virology
- Administration
- Inhalation, Intramuscular, Intranasal, Intravenous, Ophthalmic, Oral, Otic, Rectal, Topical, Vaginal
01
Overview
Highly purified staphylococcal bacteriophage preparation is a lytic bacteriophage therapy developed by the George Eliava Institute of Bacteriophage, Microbiology and Virology and manufactured by Eliava BioPreparations. It contains the well-characterized, strictly lytic Myoviridae bacteriophage Sb-1, which specifically targets and lyses *Staphylococcus aureus*, including methicillin-resistant *S. aureus* (MRSA) strains. The preparation is commercially available in Georgia for the treatment and prophylaxis of various staphylococcal infections, including skin, wound, and respiratory tract infections. It has also been utilized under compassionate use for the treatment of osteomyelitis and biofilm-associated infections.
- Brand names
- Staphylococcal bacteriophage
- Other names
- highly purified staphylococcal bacteriophageStaphylococcal monophage
02
Targets
TA (Teichoic acid)
Beyond the preview
Go deeper on highly purified staphylococcal bacteriophage preparation.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on highly purified staphylococcal bacteriophage preparation.